Free beta access. 5 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

Congress clearly supports functional bans on human germline genetic engineering.

Britta C van Beers Author Notes Rewriting the human genome, rewriting human rights law? Human rights, human dignity, and human germline modification in the CRISPR era Published: 09 June 2020 Journal of Law and the Biosciences, Volume 7, Issue 1, January-June 2020, lsaa006, https://doi.org/10.1093/jlb/lsaa006

Also in the USA, the most prolific country with regard to basic genome editing research, several legal limits to HGGE are in place. These limits are part of what has been called ‘a complex regulatory and statutory web concerned with human embryo research in general and human germline modification in particular.’ Although HGGE is not formally prohibited, currently several mechanisms, taken together, practically impede the clinical introduction of this technology. First, the National Institutes of Health, which is responsible for research funding in the USA, has stated that it ‘will not fund any use of gene-editing technologies in human embryos’. Second, the US Food and Drug Administration, which has the authority to regulate products and drugs involving gene editing, including human gene editing, has so far stood in the way of using HGGE for reproductive purposes and is also not likely to change its policy in the near future. Since December 2015, US Congress has regularly added an amendment to the FDA’s funding bill, a so-called ‘bill rider’, making it impossible for the FDA to consider any application which involves ‘research in which a human embryo is intentionally created or modified to include a heritable genetic modification’. Without the FDA’s approval, implantation of a genetically modified human embryo is illegal in the USA. However, genetically modifying human embryos for research purposes are permitted, even though such experiments remain ineligible for public funding.

Sign in to recut, update, or save this card.